JPMorgan Chase & Co’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-47
| Closed | – | – | 6169 |
|
|
2022
Q2 | $0 | Sell |
47
-341
| -88% | – | ﹤0.01% | 6261 |
|
|
2022
Q1 | $1K | Sell |
388
-1,163
| -75% | -$3K | ﹤0.01% | 5694 |
|
|
2021
Q4 | $7K | Buy |
1,551
+1,504
| +3,200% | +$6.79K | ﹤0.01% | 5488 |
|
|
2021
Q3 | $0 | Sell |
47
-71,542
| -100% | – | ﹤0.01% | 6022 |
|
|
2021
Q2 | $306K | Sell |
71,589
-12,043
| -14% | -$51.5K | ﹤0.01% | 4274 |
|
|
2021
Q1 | $355K | Buy |
83,632
+17,610
| +27% | +$74.8K | ﹤0.01% | 4210 |
|
|
2020
Q4 | $256K | Sell |
66,022
-6,997
| -10% | -$27.1K | ﹤0.01% | 4069 |
|
|
2020
Q3 | $290K | Sell |
73,019
-7,062
| -9% | -$28K | ﹤0.01% | 3595 |
|
|
2020
Q2 | $341K | Sell |
80,081
-12,830
| -14% | -$54.6K | ﹤0.01% | 3453 |
|
|
2020
Q1 | $390K | Sell |
92,911
-17,329
| -16% | -$72.7K | ﹤0.01% | 3407 |
|
|
2019
Q4 | $434K | Sell |
110,240
-9,850
| -8% | -$38.8K | ﹤0.01% | 3490 |
|
|
2019
Q3 | $1.06M | Buy |
120,090
+5,451
| +5% | +$48K | ﹤0.01% | 3041 |
|
|
2019
Q2 | $1.03M | Sell |
114,639
-7,992
| -7% | -$71.8K | ﹤0.01% | 3052 |
|
|
2019
Q1 | $789K | Sell |
122,631
-8,046
| -6% | -$51.8K | ﹤0.01% | 3147 |
|
|
2018
Q4 | $1.23M | Sell |
130,677
-7,740
| -6% | -$73K | ﹤0.01% | 2919 |
|
|
2018
Q3 | $2.79M | Buy |
138,417
+8,388
| +6% | +$169K | ﹤0.01% | 2604 |
|
|
2018
Q2 | $3.79M | Sell |
130,029
-7,115
| -5% | -$208K | ﹤0.01% | 2416 |
|
|
2018
Q1 | $4.08M | Buy |
137,144
+133,372
| +3,536% | +$3.97M | ﹤0.01% | 2340 |
|
|
2017
Q4 | $121K | Buy |
+3,772
| New | +$121K | ﹤0.01% | 3833 |
|
|
2017
Q1 | – | Sell |
-840
| Closed | -$15K | – | 4729 |
|
|
2016
Q4 | $15K | Buy |
+840
| New | +$15K | ﹤0.01% | 4209 |
|